NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









HistoSonics

HistoSonics

Private
Plymouth, MinnesotaHealthcare & Life Scienceshttps://histosonics.com/

Last Round

VC Round

Jun 22, 2026

Est. Valuation

$3.75B

Total Funding Raised

$465.3M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

HistoSonics is a medical technology company that develops a non-invasive, robotically assisted sonic beam therapy platform for liquefying and destroying targeted tissues at a sub-cellular level.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

histotripsyfocused ultrasoundnon-invasive surgerysonic beam therapyinterventional oncologytumor ablationacoustic cavitationimage-guided therapymedical roboticsbloodless surgeryscalpel-free surgeryultrasound ablationtissue liquefactionmedical devicesurgical tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HistoSonics Comparables

Compare HistoSonics with similar companies based on industry and business-model similarity.

HistoSonics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Insightec
77%
Galvanize Therapeutics
76%
SONIRE Therapeutics Inc.
76%

HistoSonics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 22, 2026
Private EquityOct 16, 2025
Buyout/LBOAug 7, 2025
IPOJan 27, 2025
Series DAug 15, 2024
VC Round
Dec 13, 2022

Key People

Founding team and executive leadership

Mike Blue

President And CEO

Executive Team

David Krenn

Chief Financial Officer

Executive Team

HistoSonics Investors

Notable investors and investment history

HistoSonics investors
InvestorRounds
Early Stage PartnersBuyout/LBO, Series B, Series A
Amzak HealthBuyout/LBO, Series D
Yonjin CapitalBuyout/LBO, Series D, VC Round, Series C Extension
Founders FundPrivate Equity
Hatteras Venture PartnersBuyout/LBO, Series B, Series A
Bezos ExpeditionsBuyout/LBO, Private Equity
State of Wisconsin Investment BoardBuyout/LBO, Series D, Series C Extension, VC Round, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Raised $3.75B post-money valuation with Yosemite and Reed Paul Jobs.

  • May 4, 2026

    Keynote speaker at DeviceTalks Minnesota on May 4, 2026.

HistoSonics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

HistoSonics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about HistoSonics's valuation, stock price, and market status.

Firmographic Details

HeadquartersPlymouth, Minnesota
Employee Range419
Year Founded2009
Last FundingJun 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.